Cancer is one of the leading causes of morbidity and mortality in the world accounting for 14 million new cases and 8 million deaths annually. Despite substantial advances in diagnosis, surgical techniques, and targeted therapeutics, metastatic disease remains the major cause of death from cancer. MTrap is developing novel therapeutic devices that interfere with the intense dialogue and crosstalk between the primary tumor and the microenvironment and represent a new disruptive approach to cancer treatment.
Investors 1
| Date | Name | Website |
| 05.08.2021 | Caixa Capi... | caixacapit... |